Mouse 4T1 Breast Tumor Model

Selective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse mammary tumor.

Aslakson, C. J., & Miller, F. R. (1992) · PubMed · Cited by 1,234 · see citing works

Cancer principles and practice of oncology

Kerin, M. J. (1997) · Surgical Oncology · doi:10.1016/s0960-7404(97)90012-8 · Cited by 744 · see citing works

Antivascular endothelial growth factor receptor (fetal liver kinase 1) monoclonal antibody inhibits tumor angiogenesis and growth of several mouse and human tumors.

Prewett, M. C., Huber, J., Li, Y., Santiago, A., O'Connor, W., King, K. D., Overholser, J. C., Hooper, A. T., Pytowski, B., Witte, L., et al. (1999) · PubMed · Cited by 660 · see citing works

Heterogeneity of tumor cells from a single mouse mammary tumor.

Dexter, D. L., Kowalski, H. M., Blazar, B. A., Fligiel, Z., Vogel, R., & Heppner, G. H. (1978) · PubMed · Cited by 579 · see citing works

A novel orthotopic model of breast cancer metastasis to bone

Lelekakis, M., Moseley, J. M., Martin, T. J., Hards, D. K., Williams, E. D., Ho, P. W. M., Lowen, D., Javni, J. A., Miller, F. R., Slavin, J., et al. (1999) · Clinical & Experimental Metastasis · doi:10.1023/a:1006689719505 · Cited by 428 · see citing works

Reduction of established spontaneous mammary carcinoma metastases following immunotherapy with major histocompatibility complex class II and B7.1 cell-based tumor vaccines.

Pulaski, B. A., & Ostrand-Rosenberg, S. (1998) · PubMed · Cited by 398 · see citing works

Antiangiogenic gene therapy targeting the endothelium-specific receptor tyrosine kinase Tie2

Lin, P. C., Buxton, J. A., Acheson, A. L., Radziejewski, C. H., Maisonpierre, P. C., Yancopoulos, G. D., Channon, K. M., Hale, L. P., Dewhirst, M. W., George, S. E., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.15.8829 · Cited by 371 · see citing works

Transcription of a novel mouse semaphorin gene, M-semaH, correlates with the metastatic ability of mouse tumor cell lines.

Christensen, C., Klingelhöfer, J., Tarabykina, S., Hulgaard, E. F., Kramerov, D. A., & Lukanidin, E. M. (1998) · PubMed · Cited by 145 · see citing works

Tumor Immunology

Sogn, J. A. (1998) · Immunity · doi:10.1016/s1074-7613(00)80641-x · Cited by 141 · see citing works

Cooperativity of Staphylococcal aureus enterotoxin B superantigen, major histocompatibility complex class II, and CD80 for immunotherapy of advanced spontaneous metastases in a clinically relevant postoperative mouse breast cancer model.

Pulaski, B. A., Terman, D. S., Khan, S., et al. (2000) · PubMed · Cited by 131 · see citing works

Screening for recurrent breast cancer--its effectiveness and prognostic value.

Tomin, R., & Donegan, W. L. (1987) · Journal of Clinical Oncology · doi:10.1200/jco.1987.5.1.62 · Cited by 130 · see citing works

Follow-up after treatment of primary breast cancer

Rutgers, E. J. T., van Slooten, E. A., & Kluck, H. M. (1989) · British journal of surgery · doi:10.1002/bjs.1800760227 · Cited by 80 · see citing works

Immunotherapy with vaccines combining MHC class II/CD80+ tumor cells with interleukin-12 reduces established metastatic disease and stimulates immune effectors and monokine induced by interferon γ

Pulaski, B. A., Clements, V. K., Pipeling, M. R., & Ostrand‐Rosenberg, S. (2000) · Cancer Immunology Immunotherapy · doi:10.1007/s002620050024 · Cited by 66 · see citing works

Central nervous system metastasis in breast cancer

Boogerd, W. J. (1996) · Radiotherapy and Oncology · doi:10.1016/0167-8140(96)01766-5 · Cited by 63 · see citing works

Chemotherapy and pattern of metastases in breast cancer patients

Amer, M. H. (1982) · Journal of Surgical Oncology · doi:10.1002/jso.2930190212 · Cited by 44 · see citing works

p53 and protein kinase C independent induction of growth arrest and apoptosis by bryostatin 1 in a highly metastatic mammary epithelial cell line: In vitro versus in vivo activity.

Wang, H., Mohammad, R. M., Werdell, J., & Shekhar, M. P. V. (1998) · International Journal of Molecular Medicine · doi:10.3892/ijmm.1.6.915 · Cited by 35 · see citing works

Induction of antitumor immunity by indomethacin

Yacovlev, E., Gelfand, Y., Morecki, S., et al. (2000) · Cancer Immunology Immunotherapy · doi:10.1007/s002620050009 · Cited by 34 · see citing works

Childhood cancer in the denver metropolitan area 1976–1983

Savitz, D. A., & Zuckerman, D. L. (1987) · Cancer · doi:10.1002/1097-0142(19870415)59:8 · Cited by 21 · see citing works

Redirecting <i>In vivo</i> Elicited Tumor Infiltrating Macrophages and Dendritic Cells towards Tumor Rejection

Guiducci, C., Vicari, A. P., Sangaletti, S., Trinchieri, G., & Colombo, M. P. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4262 · Cited by 549 · see citing works

The E3 ligase Cbl-b and TAM receptors regulate cancer metastasis via natural killer cells

Paolino, M., Choidas, A., Wallner, S., Pranjic, B., Uribesalgo, I., Loeser, S., Jamieson, A. M., Langdon, W. Y., Ikeda, F., Fededa, J. P., et al. (2014) · Nature · doi:10.1038/nature12998 · Cited by 456 · see citing works

Hypoxia and TGF-β Drive Breast Cancer Bone Metastases through Parallel Signaling Pathways in Tumor Cells and the Bone Microenvironment

Dunn, L. K., Mohammad, K. S., Fournier, P. G. J., McKenna, C. R., Davis, H. W., Niewolna, M., Peng, X. H., Chirgwin, J. M., & Guise, T. A. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006896 · Cited by 212 · see citing works

Redox-Activatable and Acid-Enhanced Nanotheranostics for Second Near-Infrared Photoacoustic Tomography and Combined Photothermal Tumor Therapy

Wang, Z., Zhen, X., Upputuri, P. K., Jiang, Y., Lau, J., Pramanik, M., Pu, K., & Xing, B. (2019) · ACS Nano · doi:10.1021/acsnano.9b01411 · Cited by 203 · see citing works

Macropinocytosis confers resistance to therapies targeting cancer anabolism

Jayashankar, V., & Edinger, A. L. (2020) · Nature Communications · doi:10.1038/s41467-020-14928-3 · Cited by 200 · see citing works

Hypoxia induces HIF1α-dependent epigenetic vulnerability in triple negative breast cancer to confer immune effector dysfunction and resistance to anti-PD-1 immunotherapy

Ma, S., Zhao, Y., Lee, W. C., Ong, L.-T., Lee, P. L., Jiang, Z., Oguz, G., Niu, Z., Liu, M., Goh, J. Y., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-31764-9 · Cited by 200 · see citing works

M7824, a novel bifunctional anti-PD-L1/TGFβ Trap fusion protein, promotes anti-tumor efficacy as monotherapy and in combination with vaccine

Knudson, K. M., Hicks, K. C., Luo, X., Chen, J.-Q., Schlom, J., & Gameiro, S. R. (2018) · OncoImmunology · doi:10.1080/2162402x.2018.1426519 · Cited by 195 · see citing works

Anticancer properties and mechanisms of fucoidan on mouse breast cancer in vitro and in vivo

Xue, M., Ge, Y., Zhang, J., Wang, Q., Hou, L., Liu, Y., Sun, L., & Li, Q. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043483 · Cited by 192 · see citing works

Differential Content of Proteins, mRNAs, and miRNAs Suggests that MDSC and Their Exosomes May Mediate Distinct Immune Suppressive Functions

Geis-Asteggiante, L., Belew, A. T., Clements, V. K., Edwards, N. J., Ostrand-Rosenberg, S., El-Sayed, N. M., & Fenselau, C. (2018) · Journal of Proteome Research · doi:10.1021/acs.jproteome.7b00646 · Cited by 104 · see citing works

Exosomal PD‐L1: New Insights Into Tumor Immune Escape Mechanisms and Therapeutic Strategies

Zhou, K., Guo, S., Li, F., Sun, Q., & Liang, G. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.569219 · Cited by 99 · see citing works

HDAC8 cooperates with SMAD3/4 complex to suppress SIRT7 and promote cell survival and migration

Tang, X., Li, G., Su, F., Cai, Y., Shi, L., Meng, Y., Liu, Z., Sun, J., Wang, M., Qian, M., et al. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa039 · Cited by 91 · see citing works

Polymeric micelles for enhanced lymphatic drug delivery to treat metastatic tumors

Qin, L., Zhang, F., Lu, X., Wei, X., Wang, J., Fang, X., Si, D., Wang, Y., Zhang, C., Yang, R., et al. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.07.005 · Cited by 80 · see citing works

Cooperative immune-mediated mechanisms of the HDAC inhibitor entinostat, an IL15 superagonist, and a cancer vaccine effectively synergize as a novel cancer therapy

Hicks, K. C., Knudson, K. M., Lee, K. L., Hamilton, D. H., Hodge, J. W., Figg, W. D., Ordentlich, P., Jones, F. R., Rabizadeh, S., Soon-Shiong, P., et al. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-0727 · Cited by 44 · see citing works

Low frequency nanobubble-enhanced ultrasound mechanotherapy for noninvasive cancer surgery

Bismuth, M., Katz, S., Mano, T., Aronovich, R., Hershkovitz, D., Exner, A. A., & Ilovitsh, T. (2022) · Nanoscale · doi:10.1039/d2nr01367c · Cited by 40 · see citing works

Surface enhanced deep Raman detection of cancer tumour through 71 mm of heterogeneous tissue

Dey, P., Vaideanu, A., Mosca, S., Salimi, M., Gardner, B., Palombo, F., Uchegbu, I., Baumberg, J., Schatzlein, A., Matousek, P., et al. (2022) · Nanotheranostics · doi:10.7150/ntno.71510 · Cited by 34 · see citing works

A pan-cancer dye for solid-tumour screening, resection and wound monitoring via short-wave and near-infrared fluorescence imaging

Mc Larney, B. E., Sonay, A. Y., Apfelbaum, E., Mostafa, N., Monette, S., Goerzen, D., Aguirre, N., Exner, R. M., Habjan, C., Isaac, E., et al. (2024) · Nature Biomedical Engineering · doi:10.1038/s41551-024-01248-w · Cited by 28 · see citing works

Anacardic 6-pentadecyl salicylic acid induces apoptosis in breast cancer tumor cells, immunostimulation in the host and decreases blood toxic effects of taxol in an animal model

Gnanaprakasam, J. N. R., López-Bañuelos, L., & Vega, L. (2021) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2020.115359 · Cited by 26 · see citing works

Transplantable Mouse Tumor Models of Breast Cancer Metastasis

Chakrabarti, R., & Kang, Y. (2015) · Methods in Molecular Biology · doi:10.1007/978-1-4939-2297-0_18 · Cited by 20 · see citing works

Primary breast tumours but not lung metastases induce protective anti-tumour immune responses after Treg-depletion

Hughes, E., Lauder, S. N., Smart, K., Bloom, A., Scott, J., Jones, E., Somerville, M., Browne, M., Blainey, A., Godkin, A., et al. (2020) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-020-02603-x · Cited by 15 · see citing works

Transforming lipid nanoparticles into radio-activatable therapeutics through synergistic ferroptosis for enhanced cancer radiotherapy

Shin, S., Bae, G.-H., Park, J. D., Koh, E.-Y., Ko, S., Han, J., Park, C. G., Kim, D.-H., Na, K., & Park, W. (2026) · Biomaterials · doi:10.1016/j.biomaterials.2026.124002 · Cited by 8 · see citing works

Serum‐derived exosomes from mice with highly metastatic breast cancer transfer increased metastatic capacity to a poorly metastatic tumor

Gorczynski, R. M., Erin, N., & Zhu, F. (2016) · Cancer Medicine · doi:10.1002/cam4.575 · Cited by 28 · see citing works

Biochemical characterization of carcinogen-induced mammary hyperplastic aveolar nodule and tumor in the rat.

Dao, T. L., Chistakos, S. S., & Varela, R. M. (1975) · PubMed · Cited by 15 · see citing works

Enhancement of spontaneous mammary tumorigenesis at advanced age in mice by temporary stimulation of mammary growth during youth

Nagasawa, H., & Ishida, M. (1986) · Life Sciences · doi:10.1016/0024-3205(86)90517-5 · Cited by 6 · see citing works

Progesterone Induced Growth Hormone and Mammary Tumorigenesis in the Dog

Yu, J. (2002) · Progress in Veterinary Medicine

Importance of mammary gland DNA synthesis on carcinogen-induced mammary tumorigenesis in rats.

Nagasawa, H., Yanai, R., & Taniguchi, H. (1976) · PubMed · Cited by 64 · see citing works